Holdings
State Street(R) SPDR(R) S&P(R) Biotech ETF
As of Jun 30, 2026, State Street(R) SPDR(R) S&P(R) Biotech ETF reported 150 positions worth US$10.7B. Largest: Apogee Therapeutics, Inc., Moderna, Inc. and Twist Bioscience Corporation. What it bought and sold, with each filing.
| Company | Shares | Value as reported | Change | As of |
|---|---|---|---|---|
| Apogee Therapeutics, Inc. | 1.2M | US$160M | +69,280 | Jun 30, 2026 |
| Moderna, Inc. | 2.16M | US$152M | +651K | Jun 30, 2026 |
| Twist Bioscience Corporation | 1.47M | US$151M | −339K | Jun 30, 2026 |
| Oruka Therapeutics, Inc. | 1.56M | US$148M | +794K | Jun 30, 2026 |
| Kymera Therapeutics, Inc. | 1.27M | US$146M | +233K | Jun 30, 2026 |
| Viking Therapeutics, Inc. | 3.59M | US$140M | +1.22M | Jun 30, 2026 |
| Praxis Precision Medicines, Inc. | 414K | US$139M | +128K | Jun 30, 2026 |
| Erasca, Inc. | 7.45M | US$136M | +2.71M | Jun 30, 2026 |
| Revolution Medicines, Inc. | 690K | US$129M | −160K | Jun 30, 2026 |
| Rhythm Pharmaceuticals, Inc. | 1.16M | US$129M | +221K | Jun 30, 2026 |